On Tuesday Mind Medicine (MMEDF) popped 17.56% on over 9 million shares while more investors were eager to buy more shares as they keep surging sharply within the last three months. After the company filed the final prospectus that is related to bought deal equity financing of $34,523,000 in Quebec City, Canada.
Testing LSD to treat mental health issues took a very long time as the scientists conduct thorough work to deliver most possibly the positive results. Other drugs are also lining up for treating different diseases that are linked to mental health. Soon MindMed will surely add one more drug to test and develop for further revenue generation.
Since mid-September MMEDF has grown over 800% and seems never to stop for a while. However, volatility will show up for two or three days to filter short term traders. Maybe, it will come back to the national exchange after surpassing $10 and showing good earnings but temporarily it will be a target for penny stock loving investors.
Editor in Chief.
Living in the era of dynamic tech change Alex decided to stay tuned in changes that make any person find comfort and adapt to new devices. Furthermore, gaming became his passion for spending leisure time with his close ones. Although, he has a degree in Business Administration (majoring in Finance) writing for technology and as well as finance has been one of the precious aspects of his life